Chemotherapy is treatment of cancer with anticancer drugs. Chemotherapy is administered in different ways, depending on the drugs to be given and the type of cancer. Doctors decide the dose of chemotherapy drugs considering many factors, among them being the patient’s height and weight.
FDA approves Adcetris to treat two types of lymphoma – The U.S. Food and Drug Administration recently approved Adcetris (brentuximab vedotin) to treat Hodgkin lymphoma (HL) and a rare lymphoma known as systemic anaplastic large cell lymphoma (ALCL).
Therapy appears to reduce rate of chemotherapy-induced early menopause for women with breast cancer – Temporarily suppressing ovarian function with use of the hormone analogue triptorelin reduced the occurrence of early menopause induced by chemotherapy among women with breast cancer, according to a study in the July_20 issue of JAMA.
Breast Cancer Patients and Families Decry FDA Panel Vote to Remove Life Saving Drug From Approved List – The Oncologic Drugs Advisory Committee, FDA, USA disapproved the Avastin which cited a lack of survival benefit. Now as two more trials have been analyzed — neither showing a survival benefit — the FDA stated that in the balance, the benefit did not outweigh the harm.
Breast cancer surgery patients benefit from adding radiation therapy – Additional radiation treatment improves disease free survival lessening the chance of cancer recurring in women with early breast cancer who have had breast conserving surgery (lumpectomy), interim results of a new study found. The results will be presented Monday, June_6 at the annual meeting of the American Society of Clinical Oncology.
U.S. Food and Drug Administration (FDA) approves Zytiga for late-stage prostate cancer – The U.S. Food and Drug Administration approved Zytiga (abiraterone acetate) in combination with prednisone (a steroid) to treat patients with late-stage (metastatic) castration-resistant prostate cancer who have received prior docetaxel (chemotherapy).
Breast cancer survivors at higher risk for falls — Cancer therapies may affect balance, according to new study in the Archives of Physical Medicine and Rehabilitation – The combined effects of chemotherapy and endocrine therapy may increase the risk of bone fractures in breast cancer survivors, revealed by researchers in a study.
FDA: Gardasil approved to prevent anal cancer – The U.S. Food and Drug Administration today approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18 in people ages 9 through 26 years.
International clinical trial tests targeted drug for melanoma — Rush University Medical Center enrolls first US patient – Rush University Medical Center has just enrolled the first U.S. patient in an international clinical trial testing a novel drug to treat certain kinds of melanoma, a deadly skin cancer that in its advanced stages currently has few effective treatments.
Cancer news articles may contribute to confusion about cancer – New research from North Carolina State University shows that most online news stories about cancer contain language that likely contributes to public uncertainty about the disease ? a significant finding, given that at least one-third of Americans seek health information online.
NewYork-Presbyterian No. 6 hospital in nation, No. 1 in NY – NewYork-Presbyterian Hospital, one of the country’s largest and most comprehensive academic medical centers, is ranked #6 in the nation and #1 among ranked hospitals in the New York area, according to U.S. News Media Group’s 2010-11 Best Hospitals.
